Search

Your search keyword '"Foulon S"' showing total 166 results

Search Constraints

Start Over You searched for: Author "Foulon S" Remove constraint Author: "Foulon S"
166 results on '"Foulon S"'

Search Results

3. A randomized phase III trial comparing trabectedin to best supportive care in patients with pre-treated soft tissue sarcoma: T-SAR, a French Sarcoma Group trial

4. ADI finite difference schemes for option pricing in the Heston model with correlation

5. A path integral approach to closed-form option pricing formulas with applications to stochastic volatility and interest rate models

6. Density of a gas of spin polarized fermions in a magnetic field

7. Confined Harmonically Interacting Spin-Polarized Fermions in a Magnetic Field: Thermodynamics

10. First multicentric randomized phase II trial investigating the antitumor efficacy of peptide receptor radionuclide therapy with 177Lutetium – Octreotate (OCLU) in unresectable progressive neuroendocrine pancreatic tumor: Results of the OCLURANDOM trial, on behalf of the ENDOCAN RENATEN network and GTE

11. 887O First multicentric randomized phase II trial investigating the antitumor efficacy of peptide receptor radionucleide therapy with 177Lutetium-Octreotate (OCLU) in unresectable progressive neuroendocrine pancreatic tumor: Results of the OCLURANDOM trial

12. 1361MO 8-month PSA strongly predicts outcomes of men with metastatic castration-sensitive prostate cancer in the PEACE-1 phase III trial

13. 1421P Effect of abiraterone-prednisone in metastatic castration-sensitive prostate cancer (mCSPC) with neuroendocrine and very high-risk features in the PEACE-1 trial

17. Contribution of X-ray Spectroscopy to Mineralogy: Exploring Platinum Using High-Energy Resolution Fluorescence Detection X-ray Absorption Spectroscopy, HERFD-XAS

18. Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 x 2 factorial design

20. 646TiP A randomized phase III, factorial design, of cabazitaxel and pelvic radiotherapy in patients with localized prostate cancer and high-risk features of relapse: The PEACE 2 trial from Unicancer

21. 603P Objective computerized cognitive assessment in men with metastatic castrate-resistant prostate cancer (mCRPC) randomly receiving darolutamide or enzalutamide in the ODENZA trial

22. LBA5 A phase III trial with a 2x2 factorial design in men with de novo metastatic castration-sensitive prostate cancer: Overall survival with abiraterone acetate plus prednisone in PEACE-1

23. 1639P Impact of COVID-19 on ongoing oncological and hematological treatment strategy

24. Qual Life Res

28. 727P Cabozantinib (Cabo) concentration (Cmin) association with toxicity (tox) and treatment failure in metastatic renal cell carcinoma (mRCC) patients: The MONICA study

29. 1688P Outcome of older cancer patients infected with COVID-19 at Gustave Roussy Cancer Center

30. Abstract

40. How should we treat castration-resistant prostate cancer patients who have received androgen deprivation therapy (ADT) plus docetaxel upfront for hormone-sensitive diseae? Mature analysis of the GETUG-AFU 15 phase III trial

41. Results of a prospective randomized phase III T-SAR trial comparing trabectedin vs best supportive care (BSC) in patients with pretreated advanced soft tissue sarcoma (ASTS)

44. Système de transmission sans fil

45. Systèmes radiofréquences avancés pour communication inter-puces multi-gigabits à 60GHz

46. ADI finite difference schemes for option pricing in the Heston model with correlation

Catalog

Books, media, physical & digital resources